Katoh K, Mizuno K, Haga H, Fukuchi S
Third Department of Internal Medicine, Fukushima Medical College, Japan.
Res Commun Chem Pathol Pharmacol. 1990 Aug;69(2):187-95.
A direct measurement of 6-keto-prostaglandin F1a (6-keto-PGF1a), a stable metabolite of prostaglandin I2, was made in the perfusate from isolated rat hind legs perfused with Krebs-Ringer solution. The rate of release of 6-keto-PGF1a was 5.28 +/- 0.24 ng during the first perfusion period of two min, and it remained stable at least for 40 min. The biological integrity of the preparation was confirmed by inhibition (52%) of 6-keto-PGF1a release by indomethacin (5 X 10(-5) M) in the perfusion medium. Low-dose infusion (5, 10, and 20 pM, for 10 min each) of endothelin (ET) elicited small but significant increment in the release of 6-keto-PGF1a in a dose-dependent fashion; the maximal per cent increase of 6-keto-PGF1a release evoked by ET (20 pM) was approximately +40% over the basal rate. These results taken together with the previous observations of synthesis of ET in the vascular tissue suggest an intriguing relationship between vasoconstrictive ET and vasodilatory prostaglandins in the local control of vascular tone.
在以 Krebs-Ringer 溶液灌注的离体大鼠后肢的灌注液中,对前列腺素 I2 的稳定代谢产物 6-酮-前列腺素 F1α(6-keto-PGF1α)进行了直接测量。在最初两分钟的灌注期内,6-酮-PGF1α 的释放速率为 5.28±0.24 纳克,并且至少在 40 分钟内保持稳定。通过在灌注介质中加入吲哚美辛(5×10⁻⁵ M)抑制 6-酮-PGF1α 释放 52%,证实了该制剂的生物学完整性。低剂量输注内皮素(ET)(5、10 和 20 皮摩尔,每次 10 分钟)以剂量依赖的方式引起 6-酮-PGF1α 释放量虽小但显著增加;ET(20 皮摩尔)引起的 6-酮-PGF1α 释放的最大百分比增加比基础速率高约 40%。这些结果与先前在血管组织中观察到的 ET 合成结果相结合,表明在局部血管张力控制中,血管收缩性的 ET 与血管舒张性前列腺素之间存在一种有趣的关系。